Form 4: Medtronic Executive Reports Share Transaction
Statement of Changes in Beneficial Ownership
Medtronic plc reports a Form 4 filing detailing changes in beneficial ownership for SVP, Chief HR Officer Walter Matthew R.
Summary
- Walter Matthew R., SVP, Chief HR Officer of Medtronic plc, filed a Form 4 statement on May 4, 2026, reporting a transaction on May 1, 2026.
- The transaction involved the disposal of 35 ordinary shares, which were withheld for the payment of taxes upon the vesting of restricted stock units.
- Following this transaction, Walter Matthew R. beneficially owns 32,380 ordinary shares directly.
- The filing also notes that the reporting person's holdings include 367 shares acquired through dividend reinvestment and 191 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine tax withholding event related to executive compensation rather than a strategic decision to buy or sell shares.
Positives
- The transaction was a tax withholding event related to vested restricted stock units, which is a common and expected occurrence for equity compensation.
- The reporting person's total direct beneficial ownership remains substantial at 32,380 shares.
- Additional shares were acquired through dividend reinvestment and an employee stock ownership plan, indicating continued participation in the company's equity programs.
Negatives
- 35 ordinary shares were disposed of as part of a tax withholding event.
Future Outlook
This filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for executives and directors regarding changes in their beneficial ownership of company stock, often related to routine compensation events like vesting and tax withholding.
Stakeholder Impact
- Shareholders: The transaction is a routine tax event for an executive and does not indicate a change in the executive's overall investment in the company, thus having minimal direct impact on shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/01/2026 | Transaction Date |
| 05/04/2026 | Date of Report |
Keywords
Form 4, Medtronic, MDT, Insider Trading, Beneficial Ownership, Stock Vesting, Tax Withholding, Executive Compensation, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.